Aleen

Aleen EBIT per Share

The EBIT per Share of Aleen (ALEN.U.CN) as of Oct 21, 2026 is -0.02 CAD. In the previous year, EBIT per Share was -0.01 CAD — a change of 117.81% (lower).

EBIT per Share

-0.02CAD

YoY

117.81%

Last updated:

EBIT per Share of Aleen is 2025 -0.02 CAD. EBIT per Share of Aleen was 2024 -0.01 CAD. It decreases by 117.81% lower compared to the previous year.

The Aleen EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
-0.01 CAD
Jan 1, 2023
-0.00 CAD
Jan 1, 2024
-0.01 CAD
Jan 1, 2025
-0.02 CAD
The Aleen EBIT per Share history
YEAREBIT per ShareYoY
-0.02CAD+117.81%
-0.01CAD+204.76%
-0.00CAD-69.42%
-0.01CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aleen Stock analysis

What does Aleen do? Aleen Inc generates revenue through its AI-powered health management platform, offering services like the Aleen Symptom Checker for preliminary diagnosis. The company targets individuals seeking self-assessment tools for health symptoms, combining AI analysis with professional medical consultation. Customers use the Aleen Symptom Checker to identify potential health issues and receive guidance on next steps, leveraging the firm's artificial intelligence to interpret personal medical indicators. The platform serves as a comprehensive tool for managing key health metrics, connecting users with healthcare professionals for further evaluation. Aleen Inc's primary product, Aleen Symptom Checker, is designed for end-users who need immediate health insights without visiting a doctor. The service integrates personal health monitoring with professional consultancy, allowing users to input symptoms and receive AI-driven suggestions. The company monetizes this by providing a digital health assessment tool that reduces unnecessary doctor visits through accurate preliminary diagnosis, appealing to health-conscious consumers in the online diagnosis market. The firm operates in the online health management sector, focusing on AI-driven symptom analysis and medical consultancy. Aleen Symptom Checker functions as the core offering, enabling users to assess symptoms and access professional advice. By combining artificial intelligence with medical expertise, Aleen Inc positions itself as a solution for individuals managing their health indicators through a digital platform, targeting users who prefer self-diagnosis tools before seeking professional help. Aleen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aleen stock

EBIT per Share of Aleen is -0.02 CAD in 2025.

EBIT per Share of Aleen changed from -0.01 CAD to -0.02 CAD, representing a 117.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Aleen since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Aleen

All Key Metrics — Aleen